Gala vs Ro: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Ro beats Gala overall, scoring 7.2/10 vs 7/10. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Ro for users who want fda-approved brand-name glp-1 access includin.
A side-by-side comparison of Gala and Ro covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaRo
#36 of 42One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Ro| Feature | Gala | Ro |
|---|---|---|
| Our Score | 7/10 | 7.2/10 |
| Starting Price | $149/mo | $149/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | Yes |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing |
| Ranking | #40 | #36 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Ro
Pros
- +Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
- +Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
- −Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Our Verdict
Ro edges out Gala with a score of 7.2/10 vs 7/10. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.